Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 307-055-2 | CAS number: 97489-15-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Sec-alkane sulfonate-sodium salts SAS is not a skin irritant when tested according to OECD guideline 404. The test followed the principles of GLP and is regarded to be valid without restrictions. In the presence of water the chemical reactivity is increased and skin irritation reactions become apparent when aqueous dilutions of sec-alkane sulfonate-sodium salts SAS are tested. This view is supported by animal data with sec-alkane sulfonate-sodium salts SAS as 60% aqueous solution, showing moderate skin irritating properties in animals. However, well documented human volunteer studies performed under GCP conditions indicate that sec-alkane sulfonate-sodium salts SAS up to aqueous concentrations of 60% active matter is not a significant skin irritant in humans
With regard to eye irritation sec-alkane sulfonate-sodium salts SAS is considered to be eye irritating. Technical grade sec-alkane sulfonate-sodium salts SAS themselves were not tested. However, findings of all available studies conducted with aqueous sec-alkane sulfonate-sodium salts SAS solutions according to OECD 405 were consistent and demonstrated concentration dependent irritant effects. sec-alkane sulfonate-sodium salts SAS is slightly irritating to eye at 15% but is irritating to eye at concentrations of 30% and above. However, when the low-volume technique is applied even a 30% aqueous solution of sec-alkane sulfonate-sodium salts SAS is not causing significant eye irritation. However, based on all available data sec-alkane sulfonate-sodium salts SAS is considered to be an eye irritant.
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Additional information
Several experimental animal studies according to GLP have consistently shown that technical grade sec-alkane sulfonate-sodium salts SAS (93%) is not exhibiting significant skin irritating properties. However, in contact with water an increased chemical reactivity is observed which may explain that sec-alkane sulfonate-sodium salts SAS when tested as 60% aqueous solution in rabbits demonstrated skin irritating properties. However, in a series of human volunteers studies no significant skin irritating properties were found even when sec-alkane sulfonate-sodium salts SAS was tested up to 60% in water. A human covered patch test according to GCP revealed only very slight but transient erythema reactions in some of the volunteers. Based hereupon, sec-alkane sulfonate-sodium salts SAS in aqueous concentrations up to 60% was not regarded to be a skin irritant in humans even under conditions comparable to animal experiments.
Four individual eye irritation studies on rabbits are available for sec-alkane sulfonate-sodium salts SAS at various aqueous concentrations of 15 up to 60 %. Findings of all studies were consistent and demonstrated concentration dependent irritant effects. sec-alkane sulfonate-sodium salts SAS as 30% aqueous solution was considered to be severely irritating to eyes whereas only slight irritating effects were observed when tested as 15% aqueous solution. However, testing of sec-alkane sulfonate-sodium salts SAS as a 30% aqueous solution for primary eye irritation using the low volume test procedure resulted in only slight irritative effects.
Effects on skin irritation/corrosion: irritating
Effects on eye irritation: highly irritating
Effect level: empty Endpoint conclusion: Adverse effect observed
Justification for classification or non-classification
Based on all available data with regard to dermal irritation, technical grade sec-alkane sulfonate-sodium salts SAS (93%) is not considered to represent a significant skin irritant when tested in animals according to OECD guideline 404. This is also supported by a series of human volunteer studies which have not demonstrated significant skin irritating effects of sec-alkane sulfonate-sodium salts SAS in aqueous concentrations up to 60%. However, due to the observed increase in reactivity when in contact with water and based on the observed significant skin irritating effects at lower aqueous test concentrations in test animals, technical grade sec-alkane sulfonate-sodium salts SAS (93%) is classified as skin irritant taking the precautionary principle into account.
Based on the results obtained for a 30% aqueous solution of sec-alkane sulfonate-sodium salts SAS in an eye irritation study, sec-alkane sulfonate-sodium salts SAS (93%) is classified as an eye irritant. With regard to eye irritation, sec-alkane sulfonate-sodium salts SAS at aqueous concentrations of 30% and higher has to be classified as eye irritant. Aqueous concentrations of sec-alkane sulfonate sodium salts SAS of 15% and lower resulted in only slight irritating effects not triggering classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.